Kolexia
Bedenne Laurent
Gastro-entérologie
Sncf Mobilites
Paris, France
97 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Adénocarcinome Tumeurs de l'oesophage Tumeurs colorectales Carcinomes Tumeurs du côlon Métastase tumorale Carcinome épidermoïde Tumeurs du rectum Carcinome hépatocellulaire

Industries

Bayer
1 collaboration(s)
Dernière en 2017
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

SURVEILLANCE: Follow-Up of Fully Resected Stage II or III Colorectal Cancer. Phase III Multicentric Prospective Randomised Study
Essai Clinique (Fédération Francophone de Cancérologie Digestive)   06 décembre 2021
Radiation Therapy and Capecitabine With or Without Oxaliplatin in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Rectal Cancer: Randomized Phase III Trial Comparing in a Preoperative Schedule the Result of Two Concurrent Chemoradiation Schemes (45 Gy + Capecitabine vs 50 Gy + Capecitabine - Oxaliplatin) on the Rate of Sterilization of the Operative Specimen in Resectable Rectal Carcinomas T3-4 No-2 Mo
Essai Clinique (Unicancer)   15 février 2021
Radiation Therapy and Chemotherapy, With or Without Cetuximab, Followed by Surgery in Treating Patients With Locally Advanced Esophageal Cancer That Can Be Removed by Surgery: Multimodal Therapy With and Without Cetuximab in Patients With Locally Advanced Esophageal Carcinoma - An Open-Label Phase III Trial
Essai Clinique (Swiss Group for Clinical Cancer Research)   19 octobre 2020
Is it still time for meta-analyses in operable esophageal cancers, or rather for a change of paradigm?
Journal of thoracic disease   01 octobre 2020
Bevacizumab+chemotherapy versus chemotherapy alone in elderly patients with untreated metastatic colorectal cancer: a randomized phase II trial-PRODIGE 20 study results.
Annals of oncology : official journal of the European Society for Medical Oncology   07 avril 2020
Surgery With or Without Radiation Therapy and Chemotherapy in Treating Patients With Esophageal Cancer: Randomized Study of Pre-Operative Radio-Chemotherapy Versus Surgery Alone in Thoracic Esophageal Cancer Deemed to be Resectable
Essai Clinique (Fédération Francophone de Cancérologie Digestive)   27 mars 2020
Neoadjuvant chemotherapy followed by chemoradiation and surgery with and without cetuximab in patients with resectable esophageal cancer: a randomized, open-label, phase III trial (SAKK 75/08).
Annals of oncology : official journal of the European Society for Medical Oncology   12 novembre 2019
E-DIS: A Multicenter Randomized Phase II Study to Evaluate the Benefit of Chemotherapy Plus Best Supportive Care (BSC) Versus BSC in Patients With Metastatic Oesophageal Cancer of Squamous Cell-type Who Have Not Experienced a Disease Progression or Unacceptable Toxicity After a 6-weeks Chemotherapy Course .
Essai Clinique (Centre Oscar-Lambret)   14 mai 2019
Bevacizumab+chemotherapy versus chemotherapy alone in elderly patients with untreated metastatic colorectal cancer: a randomized phase II trial-PRODIGE 20 study results.
Annals of oncology : official journal of the European Society for Medical Oncology   03 avril 2019
Patterns of care and outcomes in oesophageal cancer.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver   20 juillet 2018